Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BNTC compared with MOLN: revenue, margins and what each company keeps, and the suppliers and customers both name
BNTC
Benitec Biopharma Inc.
Change
Mkt cap
Revenue
Revenue
MOLN
Molecular Partners AG
Change
Mkt cap
Revenue
Revenue
vs
Compare
BNTC
Benitec Biopharma Inc.
vs
MOLN
Molecular Partners AG
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
BNTC: latest quarter is a loss; flow not drawable. MOLN: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only BNTC
2
—
Australian government
unlisted
supplier
—
Axovant Therapeutics
unlisted
customer
Shared
0
No shared counterparties.
Only MOLN
1
—
Orano Med
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
BNTC, solid
MOLN, dashed
BNTC
Benitec Biopharma Inc.
Change
8.77
▼
−0.67%
· post 8.77
Mkt cap
$304.9M
Revenue
$7,000
Q4 FY23
MOLN
Molecular Partners AG
Change
3.98
▲
+11.17%
· post 3.71
Closed
Oct 30 '26
Mkt cap
$144.5M
Revenue
—
vs
Compare
Closed
Oct 30 '26
BNTC
Benitec Biopharma Inc.
vs
MOLN
Molecular Partners AG
8.77
▼
−0.67%
post 8.77
Price
3.98
▲
+11.17%
post 3.71
$304.9M
Mkt cap
$144.5M
Q4 FY23
$7,000
Revenue
—
Change
Change
BNTC
8.77
▼
−0.67%
vs
MOLN
3.98
▲
+11.17%
Closed
Oct 30 '26